FDA Drug Recalls

Recalls / Class II

Class IID-0355-2023

Product

Diltiazem HCl in 0.7% Sodium Chloride Injection, 125 mg/125 mL (1 mg/mL), 125 mL Single-Dose Container bottle, packaged in 15 x 1 IV Bottles per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-997-15.

Affected lot / code info
Lots: DS2053, Exp. 2/27/2023

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Nephron Sterile Compounding Center LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
4500 12th Street Ext, N/A, West Columbia, South Carolina 29172-3025

Distribution

Quantity
4,743 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2023-02-22
FDA classified
2023-02-27
Posted by FDA
2023-03-08
Terminated
2024-09-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0355-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls